| Literature DB >> 11473833 |
H Hackstein1, A E Morelli, A W Thomson.
Abstract
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that play crucial roles as initiators and modulators of adaptive immune responses. Although DC-based vaccines have been utilized successfully to generate cytolytic T-cell activity against tumor antigens (Ags), evidence has accumulated that DCs also have potent capabilities to tolerize T cells in an Ag-specific manner. DCs cultured in the laboratory can suppress auto- or alloimmunity. Current and prospective strategies to promote this inherent tolerogenic potential of DCs might prove to be important for the therapy of transplant rejection and autoimmune diseases.Entities:
Mesh:
Year: 2001 PMID: 11473833 DOI: 10.1016/s1471-4906(01)01959-7
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687